DAY 1
Tuesday, 22 September 2026
08h00
Welcome Coffee & Registration
09h00
Welcome Address
- E-Lounge Auditorium
Chairman
10h00
Titre de la présentation
09h10
Introductory Keynote
- E-Lounge Auditorium
Chaired by Alain Rachon
10h00
Biomanufacturing: Market Overview and Key Dynamics
Anabelle PERRIER
Market Research Manager
MabDesign, France
09h20
Opening Keynote Lecture
- E-Lounge Auditorium
Chaired by Alain Rachon
10h00
Beyond data-driven: Rethinking process control as the blueprint for data-driving paradigm
Guillaume JEANNE
Bioprocess Mechanistic Modeling & Advanced Process Control
Sanofi, France
10h00
International Panel - Understanding the Saudi Biopharma Ecosystem: Opportunities and Realities
- E-Lounge Auditorium
Chairman
10h00
Overview of KSA Pharma & Biopharma Landscape
Eng. Khalid AL-ANAZI
Senior Manager Pharmaceuticals & Biotech
Ministry of Industry and Mineral Resources, KSA
10h15
Panel discussion
Eng. Khalid AL-ANAZI
Senior Manager Pharmaceuticals & Biotech
Ministry of Industry and Mineral Resources, KSA
Mohammed JOBRAN
Regulatory Affairs Consultant & Founder
PharmaKnowl Consulting, KSA
Ahmed Saeed MOUSA
General Manager
Lafana Life Science, KSA
Turki ALJALAJEL
Executive Director of External Affairs & Corporate Communications
Lifera, KSA
Hager BEN NASR
Regional Trade Development Advisor
Business France Middle East
10h30
Moderation
Ann GIDNER
Partner / Leader of the International Life Sciences Practice
AXCEL Partners, France
11h10
Workshops
Chairman
12h10
Lunch Break at the Exhibition Hall - B2B Meetings
13h30
Innovations in Analytical Methods Supporting Biotherapeutic Development
- E-Lounge Auditorium
Chaired by Alain Beck & Olivier Cochet
13h30
Analytical and Functional Characterization of Next-Generation Therapeutics: ADCs, CAR T Cells, rAAVs, mRNA and VLPs
Alain BECK
Senior Director Biologics CMC and Developability
Pierre Fabre Laboratories, France
14h00
Characterizing ADCs and Complex Biologics: New Insights
Dan Bach KRISTENSEN
Scientific Director
Servier Symphogen, Denmark
14h25
Scaling Analytical Automation: A Strategic Approach to Accelerate Vaccine Development
Lilian RIPOLL
Laboratory Automation Specialist
Sanofi, France
14h45
Supporting your bulk release with Next Generation Sequencing
Antoine MILLET
Viral Safety and Regulatory Affairs Specialist
Pathoquest, A Charles River Company, France
14h55
Enhancing Reliability, Usability and Environmental Robustness of At-Line Amino Acid Analysis for Upstream Bioprocessing
Jeremie BARBAU
Senior Field Application Scientist
Repligen, France
15h05
A new MAM workflow: how to implement HRMS for fast and reliable mAbs analysis
Charlotte LEKIEFFRE
Application Engineer - BioPharma
Agilent, France
Next-Generation Biotherapies: Bridging Innovation, Manufacturability and Developability
- H-Experience Auditorium
Chaired by Arnaud Delobel & Lise Besnard
13h30
Developability Across Antibody Modalities
Anne-Laure LAINE
Director Preclinical Development
Ridgeline Discovery, Switzerland
13h30
Advancing Bispecific and Multispecific Antibodies
Cyrille DREYFUS
Associate Director & Head of Protein Sciences
Ichnos Sciences, France
13h50
Automated Upstream Monitoring for Enhanced Bioprocess Performance
Charles HEBERT
CEO & Executive Board Member
GenSensor, France
14h10
From Vertical to Orchestrated Integration: The Power of an Ecosystem, Delivering Success for Biosimilars
Joe CODAMO
VP Europe & MENA
Chime Biologics, Switzerland
Anjan SELZ
CEO
Polpharma Biologics International AG, Switzerland
14h30
Upstream and Downstream Processes Intensification as a Lever for Innovative and Competitive Antibody Manufacturing
Ronan McCARTHY
Senior Purification Scientist
LFB Biomanufacturing, France
10h00
David BALBUENA
Director of Business Development
LFB Biomanufacturing, France
14h50
From Peptides to Complex Proteins: New Possibilities in Chemical Protein Synthesis
Gaël GESBERT
Business Development and Innovation Director
CliniScience, France
15h00
Optimizing Upstream Bioprocess Efficiency with GlucoSense- From Offline Sampling to Real-time Glucose Optical Control
Giovanni CAMPOLONGO
Senior Market Segment Manager Bioprocessing
Hamilton, Switzerland
15h10
Cost reduction and performance boost in bioprocess development and scale-up based on hybrid models
Riccardo DE LUCA
Senior Process Modelling Engineer
DataHow, Switzerland
15h20
Coffee Break at the Exhibition Hall - B2B Meetings
16h00
Breakthrough Innovations in Bioprocessing - Part I
- E-Lounge Auditorium
Chaired by Roland Béliard & Fabien Rousset
16h00
Oral delivery of human monoclonal antibodies produced in the milk of goats
Kaio TAVARES
Director of Research & External Innovation
Bio-Sourcing, Belgium
16h10
Towards GMP-Compatible Biofabrication and MRI-Based Quality Monitoring of Implantable Adipose Tissue Constructs
Christophe MARQUETTE
Research Director
3d.FAB – University Claude Bernard Lyon 1, France
16h20
Serum-free bioproduction of an oncolytic protozoan for immunotherapy
Cyril POUPET
Associate professor
University of Tours, France
16h30
Advancing biomolecule purification with Free-Flow Electrophoresis
Kevin FRANIATTE
In Silico Studies Manager & Scientific Director
Askleia, France
16h40
Adjusting CO2 levels to control and monitor glycosylation product quality
Christian MÜLLER
Senior Project Manager / Principal Scientist
Bioneer, Denmark
Formulation & Stability challenges During Clinical Development
- H-Experience Auditorium
Chaired by Alexandre Fontayne & Alain Rachon
10h00
In-Use Stability of Antibody-Drug Conjugates
Sandrine FLEURY-SOUVERAIN
Quality Control Laboratory Manager
Hôpitaux universitaires de Genève, Switzerland
16h00
Designing and implementing a useful quality management system for startups or research providers in the healthcare industries
Sophie MICHEL
Consultant
Sophie Michel Consulting, France
Marc DUBOURDEAU
Chairman
AMBIOTIS, France
16h30
Economic impact of drug stability in hospitals: the case of immunoconjugates
Emmanuel DOUEZ
Pharm. D. - PhD
Hospital Center and University of Tours, France
16h50
Investigating and Resolving Visible Particle Issues in Biologics Manufacturing: A Case Study
Damjan RAJAPAKSE
Senior Manager Physical-Chemistry CMC Development
Fresenius Kabi, Switzerland
17h15
Keynote Lecture
- E-Lounge Auditorium
Chairman
10h00
Beyond the Pitch: Business, Management & Performance
Thibaut CHATELARD
Senior Vice President Revenues and Marketing
Executive Committee Member, Olympique Lyonnais
18h00
Biotuesdays
- E-Lounge Auditorium
Chairman
The BioTuesday is a flagship life sciences and healthcare networking event organized by the Lyon Metropolitan Area. This special session will showcase the expertise and innovations of leading academic, clinical and industrial organizations from the Auvergne-Rhône-Alpes region, fostering exchanges and collaboration opportunities with an international audience.
10h00
Titre de la présentation
10h00
Title
Emma PETIOT
Director 3D Innovation Lab
University Lyon 1, France
10h00
Title
Magali BARBAROUX
Corporate Research Fellow
Sartorius, France
10h00
Title
Hugo TRAVARD
Innovation Manager
MGA Technologies, France
10h00
Title
Michel PROVENCE
President, Managing Director
Jubilant Biosys, France
10h00
Event Flash Update: BIO-Europe Spring 2027 – Eurexpo Lyon
19h00
Poster Session at the Exhibition Hall - Wine & Cheese
21h00